Healthcare Distribution Alliance: An Introduction
Description: Healthcare Distribution Alliance: An Introduction Will Dane Director, State Government Affairs Healthcare Distribution Alliance Virginia Health, Welfare and Institutions Committee August 3, 2020 2 HDA Antitrust Statement It is the
Related Topics
Download Presentation
"Healthcare Distribution Alliance: An Introduction" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
slide1. Healthcare Distribution Alliance: An Introduction Will Dane Director, State Government Affairs Healthcare Distribution Alliance
Virginia Health, Welfare and Institutions Committee
August 3, 2020<br>
slide2. 2 HDA Antitrust Statement It is the unqualified policy of HDA and all of its operating committees to conduct their operations in strict compliance with the antitrust laws of the United States.
HDA’s antitrust policy prohibits any discussions which constitute or imply an agreement or understanding concerning: 1) prices, discounts, or terms or conditions of sale; 2) profits, or profit margins or cost data; 3) market shares, sales territories or markets; 4) allocation of customers or territories; 5) selection, rejection or termination of customers or suppliers; 6) restricting the territory or markets in which a company may resell products; 7) restricting the customers to whom a company may sell; or 8) any matter which is inconsistent with the proposition that each member company of HDA must exercise its independent business judgment in pricing its services or products, dealing with its customers and suppliers and choosing the markets in which it will compete.
HDA membership, Board of Directors and committee meetings shall be conducted pursuant to agendas distributed in advance to attendees; discussions shall be limited to agenda items which have been reviewed by HDA legal counsel; there shall be no substantive discussions of HDA matters other than at official meetings; and minutes shall be distributed to attendees promptly upon review by HDA legal counsel.<br>
slide3. What is the role of a wholesale distributor?<br>
slide4. Pharmaceutical Distributors: A vital link in the healthcare supply chain DISTRIBUTORS ARE LOGISTICS EXPERTS.
As distributors, HDA members do not manufacture, prescribe, or promote medicines.<br>
slide5. 5 Supply Chain Without Pharmaceutical Distributors<br>
slide6. 6 Supply Chain With Pharmaceutical Distributors<br>
slide7. 7 Distributors provide between $33 and $53 billion in savings to the United States healthcare system annually. Delivering Savings & Efficiencies Providing core benefits to the pharmaceutical supply chain by:
Consolidating orders
Delivering products
Processing returns
Maintaining infrastructure & managing customer relationships Amplifying value across the healthcare ecosystem by:
Increasing operational efficiency
Providing inventory management
Bearing financial risk<br>
slide8. 8 Delivering Savings & Efficiencies Pharmaceutical wholesale distributors primarily utilize a fee-for-service model.
The pharmaceutical distribution model is a high value, high volume but very low margin industry. A recent analysis from Berkeley Research Group (BRG) shows the profit margin for a wholesaler is less than one percent of the cost of brand medicines. These findings are consistent with other reports, including analyses done by the USC, PhRMA, Wall Street Journal and Kaiser Health News.<br>
slide9. 9 Supply Chain Profits Example $300 Brand Name Drug<br>
slide10. Wholesale Distributors in Virginia HDA members serve more than 6,600 customers across the state of Virginia.
HDA members employ nearly 1,600 residents in the state.
HDA members operate 4 facilities in the state, each licensed Federally and by the Board of Pharmacy.<br>
slide11. Drug Supply Chain Security Act (DSCSA) Federal law aimed at making the supply chain as safe and efficient as possible.
Established in 2013 with a ten-year implementation.
Ultimately a traceability and uniformity solution; by 2023, the DSCSA should replace a 50-state patchwork of pedigree requirements with one solution to trace prescription medications through the supply chain.
Information: https://hda.org/Issues/Pharmaceutical-Traceability<br>
slide12. Weathering the Storm Pharmaceutical Distributors’ Role in Emergencies As the vital link in the U.S. healthcare system, HDA pharmaceutical distributors manage the safe and secure delivery of millions of medicines and healthcare products to hundreds of thousands of customers daily.
However, when a catastrophic event — such as a storm or other emergency scenario — threatens the public, distributors quickly go above and beyond.
For information specific to HDA members’ response to COVID-19, please visit www.hda.org/COVID19.<br>
slide13. LEARN MORE www.hda.org<br>
Virginia Health, Welfare and Institutions Committee
August 3, 2020<br>
slide2. 2 HDA Antitrust Statement It is the unqualified policy of HDA and all of its operating committees to conduct their operations in strict compliance with the antitrust laws of the United States.
HDA’s antitrust policy prohibits any discussions which constitute or imply an agreement or understanding concerning: 1) prices, discounts, or terms or conditions of sale; 2) profits, or profit margins or cost data; 3) market shares, sales territories or markets; 4) allocation of customers or territories; 5) selection, rejection or termination of customers or suppliers; 6) restricting the territory or markets in which a company may resell products; 7) restricting the customers to whom a company may sell; or 8) any matter which is inconsistent with the proposition that each member company of HDA must exercise its independent business judgment in pricing its services or products, dealing with its customers and suppliers and choosing the markets in which it will compete.
HDA membership, Board of Directors and committee meetings shall be conducted pursuant to agendas distributed in advance to attendees; discussions shall be limited to agenda items which have been reviewed by HDA legal counsel; there shall be no substantive discussions of HDA matters other than at official meetings; and minutes shall be distributed to attendees promptly upon review by HDA legal counsel.<br>
slide3. What is the role of a wholesale distributor?<br>
slide4. Pharmaceutical Distributors: A vital link in the healthcare supply chain DISTRIBUTORS ARE LOGISTICS EXPERTS.
As distributors, HDA members do not manufacture, prescribe, or promote medicines.<br>
slide5. 5 Supply Chain Without Pharmaceutical Distributors<br>
slide6. 6 Supply Chain With Pharmaceutical Distributors<br>
slide7. 7 Distributors provide between $33 and $53 billion in savings to the United States healthcare system annually. Delivering Savings & Efficiencies Providing core benefits to the pharmaceutical supply chain by:
Consolidating orders
Delivering products
Processing returns
Maintaining infrastructure & managing customer relationships Amplifying value across the healthcare ecosystem by:
Increasing operational efficiency
Providing inventory management
Bearing financial risk<br>
slide8. 8 Delivering Savings & Efficiencies Pharmaceutical wholesale distributors primarily utilize a fee-for-service model.
The pharmaceutical distribution model is a high value, high volume but very low margin industry. A recent analysis from Berkeley Research Group (BRG) shows the profit margin for a wholesaler is less than one percent of the cost of brand medicines. These findings are consistent with other reports, including analyses done by the USC, PhRMA, Wall Street Journal and Kaiser Health News.<br>
slide9. 9 Supply Chain Profits Example $300 Brand Name Drug<br>
slide10. Wholesale Distributors in Virginia HDA members serve more than 6,600 customers across the state of Virginia.
HDA members employ nearly 1,600 residents in the state.
HDA members operate 4 facilities in the state, each licensed Federally and by the Board of Pharmacy.<br>
slide11. Drug Supply Chain Security Act (DSCSA) Federal law aimed at making the supply chain as safe and efficient as possible.
Established in 2013 with a ten-year implementation.
Ultimately a traceability and uniformity solution; by 2023, the DSCSA should replace a 50-state patchwork of pedigree requirements with one solution to trace prescription medications through the supply chain.
Information: https://hda.org/Issues/Pharmaceutical-Traceability<br>
slide12. Weathering the Storm Pharmaceutical Distributors’ Role in Emergencies As the vital link in the U.S. healthcare system, HDA pharmaceutical distributors manage the safe and secure delivery of millions of medicines and healthcare products to hundreds of thousands of customers daily.
However, when a catastrophic event — such as a storm or other emergency scenario — threatens the public, distributors quickly go above and beyond.
For information specific to HDA members’ response to COVID-19, please visit www.hda.org/COVID19.<br>
slide13. LEARN MORE www.hda.org<br>